TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,219 | -99.3% | 15,098 | -97.9% | 0.00% | -100.0% |
| Q2 2023 | $17,471,587 | +7569.8% | 703,365 | +4543.9% | 0.02% | – |
| Q1 2023 | $227,796 | +27.0% | 15,146 | -0.1% | 0.00% | – |
| Q4 2022 | $179,437 | -28.5% | 15,168 | -64.3% | 0.00% | – |
| Q3 2022 | $251,000 | +116.4% | 42,433 | +55.7% | 0.00% | – |
| Q2 2022 | $116,000 | -38.6% | 27,259 | 0.0% | 0.00% | – |
| Q1 2022 | $189,000 | -63.5% | 27,259 | 0.0% | 0.00% | – |
| Q4 2021 | $518,000 | -96.2% | 27,259 | -93.3% | 0.00% | -100.0% |
| Q3 2021 | $13,479,000 | -18.3% | 405,016 | -4.8% | 0.01% | -18.8% |
| Q2 2021 | $16,508,000 | -23.3% | 425,563 | -4.7% | 0.02% | -27.3% |
| Q1 2021 | $21,525,000 | +53.4% | 446,587 | +65.6% | 0.02% | +37.5% |
| Q4 2020 | $14,028,000 | +1294.4% | 269,672 | +617.3% | 0.02% | +1500.0% |
| Q3 2020 | $1,006,000 | -3.7% | 37,598 | -29.9% | 0.00% | 0.0% |
| Q2 2020 | $1,045,000 | -1.0% | 53,622 | -50.0% | 0.00% | 0.0% |
| Q1 2020 | $1,056,000 | +68.2% | 107,244 | +89.4% | 0.00% | 0.0% |
| Q4 2019 | $628,000 | +97.5% | 56,619 | 0.0% | 0.00% | – |
| Q3 2019 | $318,000 | +1666.7% | 56,619 | +2572.0% | 0.00% | – |
| Q2 2019 | $18,000 | +5.9% | 2,119 | 0.0% | 0.00% | – |
| Q1 2019 | $17,000 | +88.9% | 2,119 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -25.0% | 2,119 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -50.0% | 2,119 | +15.1% | 0.00% | – |
| Q2 2018 | $24,000 | -7.7% | 1,841 | 0.0% | 0.00% | – |
| Q1 2018 | $26,000 | +4.0% | 1,841 | -39.8% | 0.00% | – |
| Q4 2017 | $25,000 | -30.6% | 3,056 | 0.0% | 0.00% | – |
| Q3 2017 | $36,000 | +16.1% | 3,056 | 0.0% | 0.00% | – |
| Q2 2017 | $31,000 | +34.8% | 3,056 | +54.5% | 0.00% | – |
| Q1 2017 | $23,000 | +155.6% | 1,978 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -35.7% | 1,978 | +5.9% | 0.00% | – |
| Q3 2016 | $14,000 | +27.3% | 1,867 | +7.1% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 1,743 | +18.7% | 0.00% | – |
| Q1 2016 | $13,000 | -18.8% | 1,469 | +8.6% | 0.00% | – |
| Q4 2015 | $16,000 | +23.1% | 1,353 | +5.9% | 0.00% | – |
| Q3 2015 | $13,000 | -35.0% | 1,278 | +8.2% | 0.00% | – |
| Q2 2015 | $20,000 | – | 1,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |